Although survival rates are increasing, brain injury continues to be a leading cause of death after cardiac arrest (CA). Permanent brain damage after CA is determined by limited tolerance to ischemia from CA and cardiopulmonary resuscitation (CPR), as well as the unique cerebral response to reperfusion after return of spontaneous circulation (ROSC). A major pathway leading to neurotoxic cascade and neuronal injury after CA involves the increased presence of reactive oxygen and nitrogen species generated during ischemia and reperfusion. The magnitude of cerebral oxidative injury induced by free radicals increased with the duration of CA (Paper I). Nitric oxide (NO), a free radical responsible for the formation of reactive nitrogen species, is increased during global ischemia from CA and reperfusion (Paper IV). Hypothetically, the administration of a drug that counteracts the overproduction of NO and also acts as a scavenger of oxygen free radicals might be warranted in order to reduce the damage caused by nitrosative and oxidative stress. For these purposes we used methylene blue (MB), an old dye that has been used in medicine for almost half a century, and an experimental pig model of 20 min of ventricular fibrillation (VF) to reflect a clinical scenario of ischemia/reperfusion injury. Administration of MB added to a hypertonic-hyperoncotic solution (MBHSD) that was started during CPR and continued for 50 min after ROSC increased short-term survival by decreasing myocardial damage, as well as cerebral peroxidation and inflammatory injury (Paper II). Immunostaining of cerebral tissue collected at different time points after CA and ROSC (Paper IV) provided experimental evidence that cortical blood-brain barrier (BBB) disruption begins as early as  during the initial phase of untreated as well as treated CA. The results indicated that MB administration reduced the neurologic injury and BBB disruption considerably, but did not reverse the ongoing detrimental processes. The demonstrated positive effects of MB were related to a decrease of nitrite/nitrate tissue content, and thus to a decrease of excess NO due to the MB inhibitory effects on NOS isoforms. A mixture of MB in hypertonic sodium lactate (MBL) was investigated to facilitate administration of MB in “the field.” Based on findings that MBL cardio- and neuroprotective properties were similar to those of MBHSD, there is reason to believe that the use of MBL might be extended during ongoing CPR and after ROSC (Paper III). It would therefore make sense to try using MB as a pharmacological neuroprotectant during or after clinical CPR in order to expand the temporal therapeutic window before other measures for neuroprotection such as hypothermia are available.

<p>Mice have become the preferred model system for studying brain function and disease. With the powerful genetic tools available, mouse models can be created to study the underlying molecular basis of neurobiology in vivo. Just as magnetic resonance imaging is the dominant tool for evaluating the human brain, high-resolution MRI--magnetic resonance microscopy (MRM)--is a useful tool for studying the brain of mouse models. However, the need for high spatial resolution limits the signal-to-noise ratio (SNR) of the MRM images. To address this problem, T1-shortening contrast agents can be used, which not only improve the tissue contrast-to-noise ratio (CNR) but also increase SNR by allowing the MR signal to recover faster between pulses. By "actively staining" the tissue with these T1-shortening agents, MRM can be performed with higher resolution, greater contrast, and shorter scan times. In this work, active staining with T1-shortening agents was used to enhance three types of in vivo mouse brain MRM: (1) angiographic imaging of the neurovasculature, (2) anatomical imaging of the brain parenchyma, and (3) functional imaging of neuronal activity.</p> <p></p> <p>For magnetic resonance angiography (MRA) of the mouse, typical contrast agents are not useful because they are quickly cleared by the body and/or extravasate from the blood pool before a high-resolution image can be acquired. To address these limitations, a novel contrast agent--SC-Gd liposomes--has been developed, which is cleared slowly by the body and is too large to extravasate from the blood pool. In this work, MRA protocols were optimized for both the standard technique (time-of-flight contrast) and SC-Gd liposomes. When the blood was stained with SC-Gd liposomes, small vessel CNR improved to 250% that of time-of-flight. The SC-Gd liposomes could also be used to reduce scan time by 75% while still improving CNR by 32%.</p> <p>For MRM of the mouse brain parenchyma, active staining has been used to make dramatic improvements in the imaging of ex vivo specimens. However for in vivo imaging, the blood-brain barrier (BBB) prevents T1-shortening agents from entering the brain parenchyma. In this work, a noninvasive technique was developed for BBB opening with microbubbles and ultrasound (BOMUS). Using BOMUS, the parenchyma of the brain could be actively stained with the T1-shortening contrast agent, Gd-DTPA, and MRM images could be acquired in vivo with unprecedented resolution (52 x 52 x 100 micrometers3) in less than 1 hour.</p> <p>Functional MRI (fMRI), which uses blood oxygen level dependant (BOLD) contrast to detect neuronal activity, has been a revolutionary technique for studying brain function in humans. However, in mice, BOLD contrast has been difficult to detect and thus routine fMRI in mice has not been feasible. An alternative approach for detecting neuronal activity uses manganese (Mn2+). Mn2+ is a T1-shortening agent that can enter depolarized neurons via calcium channels. Thus, Mn2+ is a functional contrast agent with affinity for active neurons. In this work, Mn2+ (administered with the BOMUS technique) was used to map the neuronal response to stimulation of the vibrissae. The resultant activation map showed close agreement to published maps of the posterior-lateral and anterior-medial barrel field of the primary sensory cortex.</p> <p>The use of T1-shortening agents to actively stain tissues of interest--blood, brain parenchyma, or active neurons--will facilitate the use of MRM for studying mouse models of brain development, function, and disease.</p> / Dissertation

Η ηπατική εγκεφαλοπάθεια είναι ένα σύνθετο νευροψυχιατρικό σύνδρομο το οποίο εκδηλώνεται κυρίως σε συνθήκες ηπατικής κίρρωσης. Διάφορες παθολογικές και τοξικές καταστάσεις μπορεί να επηρεάσουν την ηπατική λειτουργία σε τέτοια βαθμό ώστε να προκληθεί ηπατική εγκεφαλοπάθεια. Το οξειδωτικό στρές έχει ενεπλακεί σε διάφορες μελέτες στην παθογένεση της ηπατικής εγκεφαλοπάθειας. Επιπλέον, η ανάπτυξη αυξημένου οξειδωτικού στρές υπό την επίδραση αποφρακτικού ικτέρου έχει μετρηθεί σε διάφορα όργανα πειραματοζώων, συμπεριλαμβανομένου και του εγκεφάλου. Ο σκοπός της παρούσας μελέτης ήταν να ανιχνεύσει της αλλαγές στις αποφρακτικές συνδέσεις των τριχοειδικών αγγείων του εγκεφάλου που συσχετίζονται με την οκκλουδίνη. Για να το επιτύχουμε αυτό χρησιμοποιήσαμε ένα μοντέλο απολίνωσης του κοινού χοληδόχου πόρου (BDL) σε πειραματόζωα (αρουραίους). Στο πείραμα 1 η έκφραση της οκκλουδίνης εκτιμήθηκε μέσω της μεθόδου ποσοτικοποίησης κατά Westernblot. Σε αυτό το πείραμα χρησιμοποιήθηκαν πέντε (BDL) και πέντε ψευδώς χειρουργηθέντα πειραματόζωα (sham). Τα πειραματόζωα θανατώθηκαν δέκα ημέρες μετα το χειρουργείο. Στην κατά Westernblot ποσοτικοποίηση παρατηρήθηκε μεγάλη μείωση της ποσότητας της οκκλουδίνης στα BDL πειραματόζωα σε σχέση με τα sham. Στο πείραμα 2 χρησιμοποιήθηκαν εννέα BDL και εννέα sham πειραματόζωα. Τρία πειραματόζωα από τις δύο παραπάνω ομάδες θανατώθηκαν την πρώτη, την πέμπτη και τη δέκατη μετεγχειρητική ημέρα. Τα επίπεδα οκκουδίνης σε αυτά τα πειραματόζωα συσχετιστήκαν με τις τιμές τηςinvivo μέτρησης των ελευθέρων ριζών οξυγόνο. Τα αποτελέσματα ανέδειξαν ότι η τιμή της οκκλουδίνης στα BDL ζώα ήταν σημαντικά μειωμένη σε σχέση με τα sham όλες τις χρονικές στιγμές που έγιναν οι μετρήσεις, ενώ οι χαμηλότερες τιμές καταγράφηκαν στα πειραματόζωα που παρέμειναν υπό αποφρακτικό ίκτερο για δέκα ημέρες. Επιπλέον καταδείχθη ότι η χρονικά συσχετιζόμενη μείωση των επιπέδων της οκκλουδίνης στα ενδοθηλιακά κύτταρα του εγκεφάλου συσχετίζεται με τα αυξανόμενα επίπεδα ελευθέρων ριζών οξυγόνου της ημέρες μετά το χειρουργείο, φανερώνοντας τη σχέση μεταξύ αυτών των δύο φαινομένων. Συμπερασματικά, η παρούσα μελέτη πρώτη παραθέτει στοιχεία που προτείνουν την εμπλοκή της οκκλουδίνης στην παθοφυσιολογία της ηπατικής εγκεφαλοπάθειας σε συνθήκες εξωηπατικής χολόστασης. Αυτό γίνεται μέσω της μείωσης των επιπέδων τις οκκλουδίνης στις αποφρακτικές συνδέσεις των ενδοθηλιακών κυττάρων του εγκεφάλου υπο την επίδραση του χολοστατικού ικτέρου, η οποία οδηγεί σε άρση του αιματο-εγκεφαλικού φραγμού. / Hepatic encephalopathy in a complicate neuro-psychiatric syndrome which is common under hepatic cirrhosis. Various pathological and toxic lesions can deteriorate liver function in such way, so hepatic encephalopathy can be inflicted. Oxidative stress is involved in pathogenesis of hepatic encephalopathy in several protocols. Moreover the development of increased oxidative stress in the context of obstructive cholestasis has been proven in various rats' organs including the brain. The present study aimed to detect alterations of tight junction-associated occludin in rat brain capillaries. To accomplish that we have used a rats bile duct ligation experimental model (BDL). In experiment 1, occludin expression was evaluated by Western blot analysis. In this experiment were used five BDL and five sham rats. The experimental animals were sacrificed ten days after the operation. Western blot analysis revealed significant decrease of occlidins amount in BDL rats compared to the sham rats. In experiment 2, nine BDL and nine sham animals were used. Three animals from each group were sacrificed during the first, fifth and tenth post-operate day. The results of occludin level to these animals were associated with the in vivo superoxide radical production. The results indicated that occludin level in BDL animals, as opposed to sham-operated, was significantly reduced at every time point studied, being lowest in the rats remaining on BDL condition for 10 days. Moreover, it was demonstrated that the time-dependent reduction of occludin level in the brain endothelial was significantly correlated with the time dependent increase of brain superoxide radical level, implying a relationship between these two abnormalities. In conclusion, the evidence presented herein suggests for first time the implication of occludin in pathophysiology of hepatic encephalopathy under extra-hepatic cholestasis. This phenomenon occur due to the reduce of occludin level to cerebral endothelial cells’ tight junctions under cholestatic jaundice, which drives to lift of brain-blood barrier.

Ο αιματο-εγκεφαλικός φραγμός (ΑΕΦ) παίζει έναν καθοριστικό ρόλο στην ομοιόσταση του Κεντρικού Νευρικού Συστήματος. Οι στενοσύνδεσμοι (TJ) των ενδοθηλιακών κυττάρων των εγκεφαλικών τριχοειδών συνεισφέρουν σημαντικά στη λειτουργία του ΑΕΦ περιορίζοντας την παρακυτταρική διάχυση. Η οκλουδίνη, μια διαμεμβρανική πρωτεΐνη, αποτελεί μείζον συστατικό των TJ και παίζει σημαντικό ρόλο στη ρύθμιση της λειτουργίας τους. Το οξειδωτικό στρες αποτελεί κοινό χαρακτηριστικό πολλών νευροεκφυλιστικών και νευροφλεγμονωδών παθήσεων και η δυσλειτουργία των TJ με τη συνοδό διαταραχή του ΑΕΦ, συνδέονται με αυτό. Το αυξημένο οξειδωτικό φορτίο στα πλαίσια της αποφρακτικής χολόστασης έχει αποδειχθεί σε διάφορα όργανα αρουραίων μεταξύ των οποίων και ο εγκέφαλος. Στην παρούσα μελέτη χρησιμοποιήθηκε ένα πειραματικό μοντέλο αρουραίων με απολίνωση του χοληδόχου πόρου (BDL), για να εξεταστεί η επίδραση της χολόστασης στην εντόπιση της οκλουδίνης στο ενδοθήλιο εγκεφαλικών τριχοειδών με τη χρήση ηλεκτρονικού μικροσκοπίου. Αρσενικοί αρουραίοι Wistar χωρίστηκαν τυχαίως σε δύο ομάδες. Ομάδα Ι ψευδώς χειρουργημένοι αρουραίοι και ομάδα ΙΙ αρουραίοι που υπεβλήθησαν σε απολίνωση χοληδόχου πόρου (BDL) και οι δύο την ίδια ημέρα 0. Την 10η μετεγχειρητική ημέρα, όλα τα επιζήσαντα ζώα θυσιάστηκαν δια αποκεφαλισμού. Μετά από κατάλληλη προετοιμασία για σήμανση με ανοσοχρυσό της οκλουδίνης, δείγματα από το μετωπιαίο λοβό, το μεσεγκέφαλο και την παρεγκεφαλίδα από κάθε ομάδα παρατηρήθηκαν με ηλεκτρονικό μικροσκόπιο για διαφορές στην εντόπιση της οκλουδίνης σε σχέση με τη διενδοθηλιακή σχισμή. Τα αποτελέσματα ανέδειξαν μετακίνηση της οκλουδίνης μακριά από την περιοχή των στενοσυνδέσμων του τριχοειδικού ενδοθηλίου. Σημαντική αύξηση της απόστασης της οκλουδίνης από τη διενδοθηλιακή σχισμή παρατηρήθηκε στο μεσεγκέφαλο και στην παρεγκεφαλίδα και όχι στο μετωπιαίο λοβό, σε σχέση με την ομάδα ελέγχου (control). Τα συγκεκριμένα αποτελέσματα υπαινίσσονται μια εκλεκτική ως προς την περιοχή αποδιοργάνωση της οκλουδίνης σε απάντηση στην ηπατική δυσλειτουργία και ένα σημάδι δυσλειτουργίας των TJ με λογικό συνεπακόλουθο τη δυσλειτουργία και του ΑΕΦ. Προκαταρκτικά δεδομένα της χρήσης αντιοξειδωτικών παραγόντων, όπως η αλλοπουρινόλη, αφήνουν να διαφανεί ένας προστατευτικός ρόλος όσον αφορά τη μετατόπιση της οκλουδίνης σε BDL αρουραίους. Εν συντομία, η παρούσα πειραματική μελέτη παρουσιάζει την επίδραση του οξειδωτικού στρες, στην εντόπιση της πρωτεΐνης των στενοσυνδέσμων οκλουδίνη στο ενδοθήλιο των εγκεφαλικών τριχοειδών αγγείων σε αρουραίους με απολίνωση χοληδόχου πόρου. Για τη μελέτη χρησιμοποιήθηκαν τεχνικές ανοσοσήμανσης συνδυαζόμενες με ηλεκτρονική μικροσκοπία και παρουσιάστηκαν δεδομένα εκλεκτικής ως προς την περιοχή εγκεφαλικής δυσλειτουργίας στην ηπατική πάθηση με δυνητική συσχέτιση με τις κλινικές εκδηλώσεις της ηπατικής εγκεφαλοπάθειας. / The blood–brain barrier (BBB) plays a critical role in central nervous system homeostasis. Interendothelial tight junction (TJ) protein complexes of the brain microvasculature have a major contribution to the BBB function by limiting paracellular diffusion Occludin, a transmembrane protein, is a major component of the TJ which plays a significant role in its regulation. Oxidative stress is a major underlying cause of neurodegenerative and neuroinflammatory disorders while TJ dysfunction leading to BBB disruption is associated with it. The development of increased oxidative stress in the context of obstructive cholestasis has been proven in various rats' organs including the brain. The present study used a rat model with bile duct ligation, to examine the effect of cholestasis, to the localization of occludin in brain capillary endothelium by means of electronic microscopy. Male Wistar rats were randomly divided into Group I, rats subjected to sham operation, and Group II, rats subjected to bile duct ligation (BDL) on day 0 and on post-operative day 10 all surviving animals were sacrificed by instant decapitation. After specific treatment for immunogold labeling of occludin, samples from frontal cortex, midbrain and cerebellum from each group were observed for differences in occludin location in relation to the interendothelial cleft. The results demonstrated a dislocation of occludin away from the tight junction sites of brain endothelial cells. A significant increase of the occludin-interendothelial cleft distance was demonstrated in the midbrain and the cerebellum samples but not in the frontal cortex, compared to the control group samples. These findings imply a brain region selective derangement of occludin in response to liver disease and a sign of TJ impairment and thus, a speculated BBB dysfunction. Preliminary data of use of antioxidant agents, as allopurinol, imply a protective effect concerning the dislocation of occludin in BDL rats. In brief, this experimental study demonstrates the effect of oxidative stress, in the location of TJ protein occludin in brain capillary endothelium of BDL rats. The study used immunolabeling techniques combined with electron microscopy and presented data of region-specific brain abnormalities in liver disease with potential correlation with clinical manifestations of hepatic encephalopathy.

No description available.

The neurotoxic potential of intravenous administered benzylpenicillin (BPC) was studied in rabbits with intact blood-CNS barriers and rabbits with experimental E. coli meningitis. At onset of epileptogenic EEG activity or seizures, serum, CSF and brain tissue were collected for assay of BPC. Based on the fact that, in tissues, BPC seems to remain extracellularly, brain concentrations of BPC were expressed as brain tissue fluid (BTF) levels, calculated as lOx the concentration in whole brain tissue. Neurotoxicity could be precipitated in all rabbits. In normal rabbits BTF levels of BPC were considerably higher than those in CSF indicating a better penetration across the blood-brain barrier (BBB). BPC penetrated better to CSF and BTF in meningitic rabbits than in normal controls, suggesting some degree of damage of the BBB concomitant with meningeal inflammation. E. coli meningitis did not increase the neurotoxicity of BPC. In control rabbits the intracistemal injection of saline resulted in some degree of pleocytosis. Unmanipulated animals are therefore preferable as controls. Epileptogenic EEG-changes was the most precise of the two variables used for demonstration of neurotoxicity. EEG-changes were therefore used as neurotoxicity criterion in the following rabbit experiments. To evaluate the effect of uraemia alone and uraemia plus meningitis on the neurotoxity of BPC in rabbits, cephaloridine was used to induce uraemia. Meningitis was induced by intracistemal inoculation of a cephalosporinresistant strain of E. cloacae. Untreated  rabbits were used as controls. Uraemia resulted in increased BTF penetration of BPC, possibly explained by permeability changes in the BBB and/or decreased binding of BPC to albumin. Uraemia did not result in increased penetration of BPC into the CSF of non-meningitic rabbits. Uraemic non-meningitic rabbits had the highest BTF levels of BPC at the criterion, indicating that cephaloridine-induced renal failure increased the epileptogenic threshold in these rabbits. The combination of uraemia and meningitis increased the neurotoxicity of BPC since the criterion was reached at considerably lower BTF levels of BPC. Meningitis, either alone or together with uraemia, did not increase the neurotoxicity in comparison to control rabbits. Higher BTF levels of BPC were found in meningitic rabbits than in controls with intact blood-CNS barriers at onset of EEG-changes. In all groups of rabbits there was a pronounced variability of BPC levels in the CSF while the intra-group variations in BTF levels were much smaller. Thus, BTF and not CSF levels were decisive for the neurotoxicity of BPC. Using   the same EEG-model, the neurotoxic potential of imipenem/cilastatin (I) and a new penem derivative, FCE 22101 were compared in a cross-over study. Both I and FCE 22101 were significantly more neurotoxic than BPC. While BTF levels of the three antibiotics could be detected in all tested rabbits, detectable CSF levels were only found in one of twelve rabbits treated with I or FCE 22101, indicating that BTF concentrations rather than CSF ones are decisive for neurotoxicity of ß-lactam antibiotics. The EEG-model used was found to be a suitable model for cross-over studies of intravenously administered antibiotics. Using the "silent-second" as EEG-threshold, a CNS interaction between intraperitoneally administered BPC and intravenous thiopental was demonstrated in rats. The most probably site for this interaction is the organic acid transport system out of the CNS. Thiopental distribution in the rat brain seemed to depend not only on its lipid solubility. / <p>Diss. (sammanfattning) Umeå : Umeå universitet, 1988, härtill 5 uppsatser.</p> / digitalisering@umu

Polymere Nanopartikel sind ein vielversprechender Ansatz für die Diagnose und Therapie von Krankheiten. Sie ermöglichen den Einsatz von schwerlöslichen oder instabilen Wirkstoffen. Ein weiterer Vorteil ist die Möglichkeit das Targetings, durch gezielte Modifikationen des Nanopartikels wird der Wirkstoff zum Zielort transportiert und kann dort in der gewünschten Form freigesetzt werden; dadurch könnten bei erhöhter Wirksamkeit die Nebenwirkungen von Medikamenten reduziert werden. Ziel dieser Arbeit war die Untersuchung von physikalischen und biochemischen Eigenschaften von Nanopartikeln bestehend aus einem abbaustabilen Polystyren- Kern und einer biologisch abbaubaren Schale aus Polybutylcyanoacrylat. Es werden Methoden beschrieben, um die Größe, Struktur und den Abbau dieser Wirkstoffträger zu untersuchen. Die untersuchten Nanopartikel zeigen RAYLEIGH-Streuung, sowohl Größe als auch Abbau können durch Messung des Absorptionsspektrums bestimmt werden. Weiterhin konnten diese Eigenschaften mit Hilfe von dynamischer und statischer Lichtstreuung sowie Neutronenkleinwinkelstreuung untersucht werden. Bei letzterer Methode konnte gezeigt werden, dass die Schale größtenteils abgebaut werden kann, während der Kern intakt bleibt. In einem weiteren Teil der Arbeit wurde die Überwindung der Blut-Hirn-Schranke durch polymere Nanopartikel untersucht. Dabei wurde der fluoreszierende Thioflavine als Modellwirkstoffe eingesetzt. Das Durchdringen der Blut-Hirn-Schranke konnte nur mit Nanopartikeln erreicht werden, an deren Oberfläche ein Apolipoprotein E-Peptid gekoppelt war. Es konnte gezeigt werden, das die Nanopartikelschale im Gehirn abgebaut wird, der Wirkstoff freigesetzt wird und an Amyloid β, einem Marker der Alzheimer-Krankheit, bindet.

The developmental aspect of drug transport across the blood-brain barrier (BBB) was investigated. Microdialysis was used to study unbound morphine BBB transport at different ages in sheep. An in vitro study was performed to find differentially expressed genes in brain capillary-rich fractions of the brain in rats of different ages. Microdialysis and brain-to-plasma ratios were used to study the contribution of breast cancer resistance protein (Bcrp) to the transport of nitrofurantoin (NTF) across the BBB of rats during development as well as in adult rats and mice. A method of analysing morphine and its metabolites in plasma and microdialysis samples was developed and validated. The in vivo recovery of deuterated morphine, used as a calibrator in microdialysis experiments, was not affected by the presence of morphine in the tissue. A net influx of morphine was observed in premature lambs and adult sheep, in contrast to the efflux seen in other species. This influx decreased with age, indicating that the morphine transport across the BBB changes with age. In contrast, the transport of the morphine metabolite morphine-3-glucuronide (M3G) did not change with age. Microarray data indicated that several active transporters are differentially expressed with age. Moreover, the mRNA expression levels of Abcg2 (Bcrp) and Slc22a8 (organic anion transporter 3) changed with age when quantified using real-time polymerase chain reaction. In contrast, the expression of Abcb1 (P-glycoprotein) and occludin (a tight junction protein) did not change with age. In rats, the brain distribution of NTF decreased with age due to increased protein binding in plasma. The concentration ratio of unbound NTF across the BBB was low in the adult rat, due to intra-brain metabolism and/or efflux by other transporters. Bcrp did not appear to have a significant contribution in the developing rat or in knock-out mice compared to wild-type controls with regard to NTF BBB transport. In conclusion, in vitro studies showed that the expression levels of some genes changed with age, presumably affecting subsequent drug distribution to the brain. Further, in vivo studies showed that distribution across the BBB changed with age for morphine but not for M3G or NTF.

Le diabète de type 2 est une pathologie complexe et multifactorielle caractérisée par une hyperglycémie chronique et une résistance à l’insuline. Actuellement, le diabète de type 2 est une préoccupation majeure et mondiale de santé publique. Les objectifs de cette thèse étaient d’étudier l’impact de l’hyperglycémie (aiguë, récurrente et chronique) sur des modèles complémentaires in vivo (poisson zèbre et souris) à un niveau périphérique et central. L’hyperglycémie aiguë et/ou chronique chez le poisson zèbre a altéré l’expression génique des cytokines pro-inflammatoires du cerveau, a modulé l’expression des gènes impliqués dans l’établissement de la barrière hémato-encéphalique, a diminué la prolifération des progéniteurs neuronaux de la plupart des niches neurogéniques et a impacté les mécanismes de réparation du télencéphale. L’hyperglycémie récurrente a induit un prédiabète caractéristique chez la souris avec des altérations périphériques et centrales que la glycine a atténuées en partie. L’ensemble des résultats indique que l’hyperglycémie contribue aux dysfonctionnements observés dans le diabète au niveau de l’inflammation, du stress oxydatif, de la barrière hémato-encéphalique, de la plasticité neuronale et des processus neurogéniques, ainsi que des fonctions cognitives, et souligne le potentiel antidiabétique intéressant de la glycine. En complément de ces résultats de recherche, une mission d’enseignement orientée santé a été menée auprès d’étudiants universitaires. Cette approche holistique de la pathologie diabétique pourrait contribuer, à terme, à l’élaboration de programmes de prévention adaptés, de dépistages précoces et de thérapies efficaces. / Type 2 diabetes is a complex and multifactorial disease characterized by chronic hyperglycemia and insulin resistance. Type 2 diabetes is currently a major and worldwide public health issue. The main objectives of this thesis were to investigate the peripheral and central impact of hyperglycemia (acute, recurrent and chronic) in vivo on complementary models (zebrafish and mouse). In zebrafish, acute and/or chronic hyperglycemia modulated cerebral expression of pro-inflammaty cytokines, as well as expression of genes involved in blood-brain barrier establishment. It also reduced neural progenitor proliferation in main neurogenic niches and impaired brain repair mechanisms. In the mouse, recurrent hyperglycemia induced a characterized prediabetes with central and peripheral alterations partially alleviated by glycine. All results suggest that, hyperglycemia contributes to related diabetes dysfunctions, through inflammation and oxydative stress, on blood-brain barrier integrity, neural plasticity including neurogenesis, and cognitive functions, and highlights the antidiabetic potential of glycine. In addition, a health-oriented teaching mission has been undertaken on university students. This holistic approach on diabetic disease could help in establishing effective prevention programs, early screenings and efficient therapies.

A epilepsia é normalmente a associação de pré-disposição genética e doença ou uma lesão cerebral. Aproximadamente 1 entre 50 a 100 pessoas apresentam essa pré-disposição à convulsões. Um dos fármacos mais prescritos e utilizados para o tratamento de convulsões é o ácido valpróico (AV), tornando-se a medicação de primeira escolha no tratamento da epilepsia infantil por apresentar um amplo espectro de ação, embora apresente efeitos colaterais bastante conhecidos como pancreatite e a hepatotoxicidade, que pode ser fatal. Sistemas nanoparticulados como nanocápsulas, obtidas a partir da utilização de polímeros biodegradáveis como o polietilenoglicol (PEG) e macromoléculas naturais como a quitosana (QS), que proporcionam hidrofilia e bioadesividade, têm sido estudadas com o objetivo de aumentar a penetração cerebral e reduzir a dosagem do fármaco. Nesse contexto, o presente trabalho teve como objetivo desenvolver e caracterizar físico-quimicamente nanocápsulas de poli(ε-caprolactona) contendo AV e revestidas com QS (NCQ) e/ou com PEG 6000 (NCP e NCQP), investigar a farmacocinética plasmática, a penetração do AV através da barreira hematoencefálica (BHE) por microdiálise e a hepatotoxicidade em ratos Wistar. Nanocápsulas revestidas com QS (NCQ) foram obtidas pelo método de nanoprecipitação do polímero pré-formado seguido do revestimento com adição de 5 mL de solução de QS a 1%. Para a preparação de NCP, foi utilizada metodologia similar adicionando 0,7% de PEG 6000 na fase aquosa. Para a preparação de NCQP, as nanocápsulas preparadas com a adição de 0,35% de PEG 6000 e revestidas posteriormente com solução de QS a 1% (2,5 mL). As formulações foram caracterizadas físico-quimicamente avaliando-se o tamanho das partículas, potencial zeta, pH e taxa de incorporação. As nanocápsulas foram visualizadas por MET e a estabilidade foi investigada por retroespalhamento de luz (Turbiscan Lab®). As formulações (AV 5 mg/mL) apresentaram um pequeno tamanho de partícula (144,2 ± 2,0 nm, 153,2 ± 1,8 nm, e 231,3 ± 15,6 nm, para NCQ, NCP e NCQP, respectivamente), com baixo índice de polidispersão, alta taxa de incorporação (95 a 98 %), pH ácido, potencial zeta positivo para NCQ (+8,7 ± 0,4 mV) e negativo para NCP (- 6,6 ± 0,8 mV) e NCQP (- 2,8 ± 1,3 mV). As fotomicrografias mostraram partículas de forma esférica e as formulações demonstraram boa estabilidade durante 24h de análise a 40°C. As concentrações plasmáticas foram investigadas em ratos Wistar (15 mg/kg via i.v. de AV) para todas as formulações e valproato sódico (grupo controle). A análise farmacocinética compartimental apresentou uma distribuição muito rápida para o AV em NCQ e a ASC0-∞ aproximadamente duas vezes menor em comparação à NCP, NCQP e o fármaco livre (3874 ± 1775; 8280 ± 2136; 7849 ± 1021 e 7978 ± 3622 μg/mL/min, respectivamente). O clearance do AV aumentou significativamente para NCQ (0,284 ± 0,156 L/h/kg) (α = 0,05%). A penetração do AV através da BHE foi realizada em ratos Wistar acordados por microdiálise (MD) cerebral, no córtex frontal utilizando sondas CMA/12 (3 mm). Os experimentos de MD mostraram um aumento de 5 vezes no fator de penetração cerebral após a administração de NCQ em comparação com o fármaco em solução (0,110 and 0,021, respectivamente), demonstrando a viabilidade da utilização de QS como polímero de revestimento objetivando a BHE. A NCP demonstrou um aumento de 1,7 vezes no fator de penetração cerebral e NCQP não demonstrou qualquer diferença na penetração. A investigação da hepatotoxicidade do AV foi realizada após cinco dias de tratamento (dose de 30 mg/kg q12h de AV) em solução ou em nanocápsulas (NCQ ou NCP) com grupo controle de solução salina. Os níveis séricos de asparto aminotransferase (AST), alanina aminotransferase (ALT), gama-glutamiltransferase (GGT), fosfatase alcalina (FAL), creatinina (CRE) e uréia foram determinados. Os resultados mostram a manutenção dos níveis normais de enzimas hepáticas como a ALT e FAL para NCQ (54,2 ± 11,2 UI/mL and 149 ± 26 UI/mL) demonstrando um efeito hepatoprotetor não observado para os outros grupos. Análises histológicas do fígado dos animais não apresentaram a formação de esteatose microvesicular para NCQ em comparação com a formação de esteatoses em todos os outros grupos, incluindo o grupo controle. Ao final, os resultados indicaram que NCQ possa ser uma formulação em potencial, necessitando ser investigada pelo aumento da penetração cerebral de AV e efeito hepatoprotetor observados. / Epilepsy is usually a combination of genetic pre-disposition and a disease or a brain damage. About 1 in 50 to 100 people has this genetic predisposition to seizures. One of the world’s most prescribed drugs to treat epileptic seizures is valproic acid (VA), which is the first choice drug to treat epilepsy in childhood due to its broad spectrum of action, although its well known side effects such as pancreatitis, hepatotoxicity can be fatal. Nanoparticulated systems such as nanocapsules, obtained from biodegradable polymers like polyethylene glycol and natural macromolecules like chitosan, who gives the system hidrophilicity and bioadhesivity, have been used to increase brain penetration and reduce drug doses. In this context, the present work aimed to develop and physicochemically characterize poly(ε-caprolactone) nanocapsules loaded with VA and coated with chitosan (NCQ) and/or polyethylene glycol (PEG) 6000 (NCP and NCQP), and to investigate their plasma pharmacokinetics, VA blood-brain barrier penetration (BBB) by microdialysis and hepatotoxicity in Wistar rats. Nanocapsules coated with chitosan were obtained by nanoprecipitation of preformed polymer followed by coating with 1% chitosan solution added prior to final adjustments at a volume of 5 mL. For NCP preparation, similar methodology was used adding 0.7% PEG 6000 in the aqueous phase. For NCQP preparation, the nanocapsules prepared with PEG 6000 (0.35% w/v) was further coated with chitosan 1% in solution adding 2.5 mL prior to the final adjustments. The formulations were physicochemical characterized by particle size, zeta potential, pH, incorporation efficiency. The particles were visualized by MET and the stability investigated by backscattering (Turbiscan Lab®). The formulations (VA 5 mg/mL) presented small particle sizes (144.2 ± 2.0 nm, 153.2 ± 1.8 nm, and 231.3 ± 15.6 nm, for NCQ, NCP and NCQP, respectively), with low polidispersion index, high incorporation efficiency (95 to 98 %) and acid pH. The zeta potential was positive for NCQ (+8.7 ± 0.4 mV) and negative for NCP (- 6.6 ± 0.8 mV) and NCQP (- 2.8 ± 1.3 mV). The photomicrography of all formulations showed spherically shaped particles. The formulations showed good stability during 24 hours investigation at 40 ºC. Plasma concentrations were investigated in Wisar rats after 15 mg/kg i.v. dosing of all formulations and sodium valproate solution (control group). The pharmacokinetic compartmental analysis showed a very rapid distribution of VA when incorporated in NCQ in comparison to the other formulations and the AUC0-∞ about two times lower in comparison to NCP, NCQP and the drug alone (3874 ± 1775; 8280 ±2136; 7849 ± 1021 and 7978 ± 3622 μg/mL/min, respectively). VA clearance was significantly increased after NCQ dosing (0.284 ± 0.156 L/h/kg) (α = 0.05 %). Drug penetration through BBB was performed in awaken Wistar rats by brain microdialysis at the frontal cortex using CMA/12 probes (3 mm). The microdialysis experiments showed a five times increase in VA brain penetration factor after NCQ administration in comparison to drug alone (0.110 and 0.021, respectively), demonstrating the viability of chitosan as coating polymer to aim the BBB. NCP showed only a 1.7 times increase in brain penetration factor and NCQP did not showed any difference in comparison to drug alone. The investigation of drug hepatotoxicity was conducted after 5 days i.v. dosing of VA 30 mg/kg q12h as solution or nanocapsules (NCQ or NCP). A saline control group was also investigated. Serum levels of asparte aminotransferase, alanine aminotransferase, gamma-glutamyltransferase, alkaline phosfatase, creatinin and urea were determined. The results showed the maintenance of normal levels of hepatic enzymes such as alanine aminotransferase and alkaline phosfatase for NCQ (54.2 ± 11.2 IU/mL and 149 ± 26 IU/mL) showing a hepatoprotective effect not observed in the other groups investigated. Histological analysis of animals livers showed no microvesicular steatosis formation when NCQ was administered in comparison with the formation of steatosis in all other groups including control. Overall the results indicate that NCQ is a potential formulation to be investigated for the treatment of epilepsy due to its increase in VA brain penetration and hepatoprotective effect observed.